CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Hikal Ltd Company Snapshot
Hikal Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Hikal Ltd with three other companies in this sector in India: Dishman Carbogen Amcis Ltd (2019 sales of 20.59 billion Indian Rupees [US$290.47 million] of which 71% was CRAMS), Aarti Drugs Limited (15.61 billion Indian Rupees [US$220.25 million] of which 100% was Pharmaceuticals), and Ajanta Pharma Limited (20.55 billion Indian Rupees [US$290.01 million] of which 100% was Pharmaceutcals).

Sales Analysis. Hikal Ltd reported sales of 15.90 billion Indian Rupees (US$224.29 million) for the fiscal year ending March of 2019. This represents an increase of 22.6% versus 2018, when the company's sales were 12.96 billion Indian Rupees. Sales at Hikal Ltd have increased during each of the previous five years (and since 2014, sales have increased a total of 92%). Sales of Pharmaceutical Products saw an increase of 24.8% in 2019, from 7.53 billion Indian Rupees to 9.39 billion Indian Rupees.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Hikal Ltd
  Stock Performance Chart for Hikal Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (1/10/2020): 117.85
(Figures in Indian Rupees)
1 Week -4.0%   13 Weeks 8.3%  
4 Weeks -17.6%   52 Weeks -25.3%  
 
Hikal Ltd Key Data:
  Ticker: HIKAL Country: India
  Exchanges: OTH BOM Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 15,896,090,000
(Year Ending Jan 2020).
Employees: 1,587
  Currency: Indian Rupees Market Cap: 14,530,905,000
  Fiscal Yr Ends: March Shares Outstanding: 123,300,000
  Share Type: Ordinary Closely Held Shares: 86,886,954
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.